MedTrace Logo

Alberta Cancer Exercise Hybrid Effectiveness-Implementation Study

NCT02984163 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 2570

Last updated 2025-08-21

No results posted yet for this study

Summary

The primary purpose of this proposed 5-year hybrid effectiveness and implementation study is to evaluate the relative benefit from, and implementation of an Alberta wide clinic-to-community-based cancer and exercise model of care - the Alberta Cancer Exercise (ACE) Program. The investigators hypothesize that the strategy will improve the physical well-being and QoL of survivors (on and off cancer treatment) while preventing the development of secondary cancers.

Conditions

  • Neoplasms

Interventions

BEHAVIORAL

Exercise

Exercise sessions will include a combination of aerobic, resistance, balance, and flexibility exercises delivered in a circuit-type class setting or group personal training format.

Sponsors & Collaborators

  • University of Calgary

    collaborator OTHER

  • Alberta Health services

    collaborator OTHER

  • Cross Cancer Institute

    collaborator OTHER

  • Tom Baker Cancer Centre

    collaborator OTHER

  • University of Alberta

    lead OTHER

Principal Investigators

  • Margaret L McNeely, PT, PhD · University of Alberta

  • Nicole Culos-Reed, PhD · University of Calgary

Study Design

Allocation
NA
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-01-09
Primary Completion
2024-09-30
Completion
2026-06-30

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02984163 on ClinicalTrials.gov